NCT01041092
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Fundació Sant Joan de Déu Esplugues de Llobregat, Spain
Clinical trial condition
Schizophrenia
Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.
2,710 public trials
267 recruiting studies
Schizophrenia trial results
Completed
SWitching to Abilify Trial (SWAT)
NCT00304616
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT00304655
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00520650
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Changhua Christian Hospital Changhua, Taiwan
- National Taiwan University Hospital Yun-Lin Branch Douliu, Taiwan
- Cardinal Tien Hospital Hsin Chu Mercy Branch Hsinchu, Taiwan
- Buddhist Tzu Chi General Hospital Hualien City, Taiwan
NCT00499044
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Freedom Trail Clinic, Massachusetts General Hospital Boston, Massachusetts, United States
NCT00140166
- Conditions
- Acute Schizophrenia, Mental Disorders, Schizophrenia, +1 more
- Locations
-
- Beersheva Mental Health Center Beersheva, Israel
NCT00541398
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- CNSR Glostrup Municipality, Denmark
NCT00418171
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Pfizer Investigational Site San Bernardino, California, United States
- Pfizer Investigational Site ‘Aiea, Hawaii, United States
- Pfizer Investigational Site Schaumburg, Illinois, United States
- Pfizer Investigational Site Grants Pass, Oregon, United States
Completed
A Study for Patients With Schizophrenia
NCT00520923
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Banfield, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lanús Este, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munro, Argentina
Completed
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
NCT00996242
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Sahlgrenska Univeristy Hospital Gothenburg, Sweden